Plavix and Inflammatory marker increased - a phase IV clinical study of FDA data

Summary:

Inflammatory marker increased is reported as a side effect among people who take Plavix (clopidogrel bisulfate), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Humira, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Inflammatory marker increased when taking Plavix. It is created by eHealthMe based on reports of 147,094 people who have side effects when taking Plavix from the FDA, and is updated regularly.

What is Plavix?

Plavix has active ingredients of clopidogrel bisulfate. It is often used in stent. eHealthMe is studying from 151,178 Plavix users. Check the latest studies of Plavix.

What is Inflammatory marker increased?

Inflammatory marker increased is found to be associated with 396 drugs and 391 conditions by eHealthMe. Check the latest studies of Inflammatory marker increased.

On Jul, 26, 2026

147,094 people reported to have side effects when taking Plavix.
Among them, 11 people (0.01%) have Inflammatory marker increased.

Could Plavix cause Inflammatory marker increased?

Among these 11 people:

How long have people been on Plavix when they have Inflammatory marker increased? *

What is the gender of people who have Inflammatory marker increased when taking Plavix? *

female: 54.55 %
male: 45.45 %

What is the age of people who have Inflammatory marker increased when taking Plavix? *

What are other drugs people take besides Plavix? *

What are other side effects people have besides Inflammatory marker increased? *

General Physical Health Deterioration (weak health status): 5 people, 45.45%
Headache (pain in head): 3 people, 27.27%
Acute Kidney Failure: 3 people, 27.27%
Dementia (madness): 3 people, 27.27%
Confusion: 3 people, 27.27%
Confusional State: 3 people, 27.27%
Diarrhea: 2 people, 18.18%
Lung Disorder (lung disease): 2 people, 18.18%
Memory Loss: 2 people, 18.18%
Mobility Decreased (ability to move is reduced): 2 people, 18.18%

What are the existing conditions these people have? *

High Blood Pressure: 3 people, 27.27%
Pain: 3 people, 27.27%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 27.27%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 2 people, 18.18%
Drug Hypersensitivity: 2 people, 18.18%
Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium): 2 people, 18.18%
Urinary Tract Infection: 2 people, 18.18%
Muscle Spasms (muscle contraction): 1 person, 9.09%
Infection: 1 person, 9.09%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Plavix and have Inflammatory marker increased?

- Check whether Inflammatory marker increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Plavix:

Plavix (151,178 reports)

Browse all side effects of Plavix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Inflammatory marker increased:

Inflammatory marker increased (396 drugs)

Browse all the conditions that are associated with Inflammatory marker increased:

Inflammatory marker increased (391 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clopidogrel bisulfate (the active ingredients of Plavix) and Plavix (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.